Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03270176
Title A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Debiopharm International SA

Advanced Solid Tumor

lung non-small cell carcinoma


Avelumab + Xevinapant

Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST